Bookmarkers beware: Bookmarks to pages other than the home page may not work after we change our server in April

Editor's Choice | This Week in BMJ | Press releases


BMJ No 7129 Volume 316

Papers - Abstracts Saturday 7 February 1998


Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden
Single dose vitamin A treatment in acute shigellosis in Bangladeshi children: randomised double blind controlled trial
Mortality from overdose among injecting drug users recently released from prison: database linkage study
Evaluation of adjuvant psychological therapy in patients with testicular cancer: randomised controlled trial
Evaluation of reagent strips in detecting asymptomatic bacteriuria in early pregnancy: prospective case series
Qualitative study of educational interaction between general practitioners and specialists

Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden

Olof Nyrén, Li Yin, Staffan Josefsson, Joseph K McLaughlin, William J Blot, Martin Engqvist, Lars Hakelius, John D Boice Jr, Hans-Olov Adami

See Editorial by Cooper and Dennison, p 403 and Letter, p 477

Abstract

Objective: To examine the relation between connective tissue disease and related conditions and breast implants.
Design: Retrospective cohort study of all women in the Swedish national inpatient registry who underwent breast augmentation surgery with artificial implants during 1964-93, compared with women who underwent breast reduction surgery during the same period.

Setting: Sweden.

Subjects: 7,442 women with implants for cosmetic reasons or for reconstruction after breast cancer surgery and 3353 women with breast reduction surgery.

Main outcome measures: Subsequent hospitalisation for definite connective tissue diseases (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, dermatomyositis, and Sjögren's syndrome) or related disorders.

Results: 29 women with implants were hospitalised for definite connective tissue disease compared with 25.5 expected based on general population rates (standardised hospitalisation ratio 1.1 (95% confidence interval 0.8 to 1.6)). There were no diagnoses of systemic sclerosis, and no significant excess in risk for polymyalgia rheumatica, fibromyalgia, and several related disorders. Among women who underwent breast reduction surgery, 14 were hospitalised for definite connective tissue disease compared with 10.5 expected (standardised hospitalisation ratio 1.3 (0.7 to 2.2)). Compared with the breast reduction group, women with breast implants showed a slight reduction for all definite connective tissue disease (relative risk 0.8 (95% confidence interval 0.5 to 1.4)).

Conclusions: This large nationwide cohort study shows no evidence of association between breast implants and connective tissue disease.

Department of Medical Epidemiology,
Karolinska Institute,
PO Box 281,
S-171 77 Stockholm,
Sweden
Olof Nyrén, associate professor
Li Yin, statistician
Staffan Josefsson, programmer

International Epidemiology Institute,
Rockville,
Maryland,
USA
Joseph K McLaughlin, senior scientist
William J Blot, senior scientist
John D Boice Jr, senior scientist

National Board of Health and Welfare,
Stockholm,
Sweden
Martin Engqvist, register coordinator

Department of Plastic and Hand Surgery,
University Hospital,
Uppsala,
Sweden
Lars Hakelius, professor

Department of Epidemiology,
Harvard School of Public Health,
Boston,
Massachusetts,
USA
Hans-Olov Adami, adjunct professor

Correspondence to: Dr Nyrén

email: Olof.Nyren@mep.ki.se

Full text on BioMedNet


Single dose vitamin A treatment in acute shigellosis in Bangladeshi children: randomised double blind controlled trial

Shahadat Hossain, Rabi Biswas, Iqbal Kabir, Shafique Sarker, Michael Dibley, George Fuchs, Dilip Mahalanabis

Abstract

Objective: To evaluate the efficacy of a single large oral dose of vitamin A in treating acute shigellosis in children in Bangladesh.

Design: Randomised double blind controlled clinical trial.

Setting: Dhaka Hospital, International Centre for Diarrhoeal Disease Research, Bangladesh.

Subjects: 83 children aged 1-7 years with bacteriologically proved shigellosis but no clinical signs of vitamin A deficiency; 42 were randomised to treatment with vitamin A and 41 formed a control group.

Intervention: Children were given a single oral dose of 200,000 IU of vitamin A plus 25 IU vitamin E or a control preparation of 25 IU vitamin E.

Main outcome measures: Clinical cure on study day 5 and bacteriological cure.

Results: Baseline characteristics of the subjects in the two treatment groups were similar. Significantly more children in the vitamin A group than in the control group achieved clinical cure (19/42 (45%) versus 8/14 (20%); chi2=5.14, 1 df, P=0.02; risk ratio=0.68 (95% confidence interval: 0.50 to 0.93)). When cure was determined bacteriologically, the groups had similar rates (16/42 (38%) versus 16/41 (39%); chi2=0.02, 1 df, P=0.89; risk ratio=0.98 (0.70 to 1.39)).

Conclusions: Vitamin A reduces the severity of acute shigellosis in children living in areas where vitamin A deficiency is a major public health problem.

Clinical Sciences Division,
International Centre for Diarrhoeal Disease Research,
Bangladesh,
GPO Box 128,
Dhaka 1000,
Bangladesh
Shahadat Hossain, senior medical officer
Rabi Biswas, research assistant
Iqbal Kabir, scientist
Shafique Sarker, associate scientist
George Fuchs, director
Dilip Mahalanabis, former director

Centre for Clinical Epidemiology and Biostatistics,
University of Newcastle,
Newcastle,
NSW 2300,
Australia
Michael Dibley, senior lecturer

Correspondence to: Dr Hossain

email: shossain@icddrb.org

Full text on BioMedNet


Mortality from overdose among injecting drug users recently released from prison: database linkage study

S R Seaman, R P Brettle, S M Gore

Abstract

Objective: To assess whether injecting drug users have a higher than usual risk of death from overdose in the 2 weeks after release from prison.

Design: Soundex coding of surnames and information on date of birth were used to link entry and release dates from the local prison between 1983 and 1994 with clinical data from Edinburgh City Hospital's cohort of male injecting drug users who are infected with HIV.

Setting: Edinburgh City Hospital and Edinburgh Prison.

Subjects: 316/332 male injecting drug users infected with HIV in the City Hospital HIV cohort; 16 were excluded because they were enrolled after developing AIDS or because their precise date of death was not available.

Main outcome measure: Relative risk of dying from overdose before developing AIDS and relative risk of dying of all causes before developing AIDS during the 2 weeks after release from prison; this was compared with relative risks of death during other time at liberty.

Results: 238/316 (75%) injecting drug users served time in the prison between 1983 and 1994. 33 out of 316 injecting drug users who were infected with HIV died before developing AIDS during 517 177 days at risk. 20 of these men died of an overdose; 6 of these deaths occurred within 2 weeks of release during 5903 days at risk. Death rates from overdose before the development of AIDS were 1.02/1000 days during the 2 weeks after release (recently released) and 0.029/1000 days during other times of liberty. The relative risk of death from overdose became 7.7 (1.5 to 39.1) after temporal matching (when the comparison was limited to the first 2 weeks after release versus the next 10 weeks). The crude relative risk in an analysis combining stratified prison term and the 2 weeks after release was 4.5 (1.7 to 11.7) for death from overdose. After temporal matching these risks became 1.8 (0.4 to 9.2).

Conclusion: Prisons should evaluate interventions to reduce the risk of death from overdose after release.

Medical Research Council Biostatistics Unit,
Institute of Public Health,
Cambridge CB2 2SR
S R Seaman, PhD student
S M Gore, senior statistician

Regional Infectious Diseases Unit,
City Hospital,
Edinburgh EH11 3XA
R P Brettle, consultant

Correspondence to: Dr Gore

email: sheila.gore@mrc-bsu.cam.ac.uk

Full text on BioMedNet


Evaluation of adjuvant psychological therapy in patients with testicular cancer: randomised controlled trial

C Moynihan, J M Bliss, J Davidson, L Burchell, A Horwich

Abstract

Objective: To determine the efficacy of adjuvant psychological therapy in patients with testicular cancer and to compare the characteristics and psychosocial outcomes of men who agreed to participate with those who declined to participate in a randomised trial of psychological intervention.

Design: Newly diagnosed patients were asked to participate in a randomised trial of psychological support compared with standard medical care. Participants and non-participants completed self assessment questionnaires at baseline and at 2, 4 and 12 months.

Setting: Testicular Tumour Unit of the Royal Marsden Hospital.

Subjects: 73 of 184 (40%) eligible patients agreed to enter the randomised trial (participants) and 81 (44%) declined to participate but agreed to complete further assessments (non-participants). 30 patients wanted no further contact with the researchers.

Outcome measures: Hospital anxiety and depression scale, psychosocial adjustment to illness scale, Rotterdam symptom checklist, mental adjustment to cancer scale. Only scores on the hospital anxiety and depression scale are reported for evaluating treatment efficacy.

Results: 111 of 184 (60%) eligible men declined to participate in the trial. Patients with stage I disease were most likely to refuse to participate. A patient was less likely to participate if he had low volume disease and was receiving no further treatment. Likelihood of participation was associated with stage of disease and with type of primary treatment (P<0.001 for heterogeneity). Patients with early stage disease (P<0.001) and fewer physical symptoms (P<0.001) were less likely to participate. Psychosocial factors associated with participation included anxious preoccupation regarding disease (P=0.01). There were no differences in outcome between participants and non-participants during follow up. Patients seemed to gain little benefit from adjuvant psychological therapy. At 2 months change from baseline favoured the treated group in the anxiety subscale (mean difference between groups -1.41 (95% confidence interval -2.86 to 0.03)). This was not sustained when adjusted for factors related to the disease. By 12 months change from baseline seemed to favour the control group (mean difference between groups 1.66 (-0.18 to 3.50)).

Conclusions: Patients with testicular cancer seem to have considerable coping abilities. Those who declined to participate in the trial differed from those who participated. Those who agreed to participate may comprise the clinical group who perceive a need for psychological support. No evidence was found to indicate a need for routinely offering adjuvant psychological therapy.

Academic Department of Radiotherapy and Oncology,
Royal Marsden NHS Trust,
Sutton,
Surrey SM2 5PT
C Moynihan, medical sociologist
L Burchell, research assistant
A Horwich, professor of radiotherapy and oncology

Clinical Trials and Statistics Unit,
Section of Epidemiology,
Institute of Cancer Research,
Sutton,
Surrey SM2 5NG
J M Bliss, statistician
J Davidson, data manager

Correspondence to: Ms Moynihan

email: clare@icr.ac.uk

Full text on BioMedNet


Evaluation of reagent strips in detecting asymptomatic bacteriuria in early pregnancy: prospective case series

Douglas G Tincello, David H Richmond

Abstract

Objective: To evaluate the performance of reagent test strips in screening pregnant women for asymptomatic bacteriuria at their first visit to an antenatal clinic.

Design: Prospective case series.

Setting: Antenatal clinic of a large inner city maternity hospital.

Subjects: All women attending for their first antenatal clinic. Patients taking antibiotics for any reason and those with urinary tract symptoms were excluded.

Intervention: A midstream urine specimen was divided; half was sent for microscopy and formal bacteriological culture and the other half was tested with a commercial reagent strip test for the presence of blood, protein, nitrite, and leucocyte esterase.

Main outcome measures: Sensitivity, specificity, and positive and negative predictive values of the reagent strips in diagnosing asymptomatic bacteriuria (defined as 105 colony forming units/ml urine).

Results: Sensitivity was low, with a maximum of 33% when all four tests were used in combination. Specificity was high, with typical values of 99% or more. Positive predictive value reached a maximum of 69% and negative predictive value was typically 95% or more.

Conclusion: Urine reagent strips are not sufficiently sensitive to be of use in the screening for asymptomatic bacteriuria and therefore many patients would be missed. In view of the potentially serious sequelae of this condition in pregnant women we recommend that formal bacteriological investigation remain the investigation of choice in this group of patients.

Department of Urogynaecology,
Liverpool Women's Hospital,
Liverpool L8 7SS
Douglas G Tincello, research registrar
David H Richmond, consultant gynaecologist

Correspondence to: Dr Tincello

Full text on BioMedNet


Qualitative study of educational interaction between general practitioners and specialists

Martin N Marshall

Abstract

Objectives: To identify the main barriers to effective educational interaction between general practitioners and specialists and to suggest ways of overcoming these barriers.

Design: Qualitative study using semistructured interviews and focus groups. A content analysis of the data was performed.

Setting: South and West Regional Health Authority.

Subjects: 12 general practitioner principals and 12 hospital consultants were sampled purposefully and underwent a semistructured interview; a further 16 general practitioners and 16 hospital consultants similarly sampled made up four focus groups representing the two branches of the medical profession.

Results: There was a mismatch between what the general practitioners wanted from specialists in educational terms, and what the specialists were providing. General practitioners wanted to learn information that was directly applicable to their clinical work and to use referrals as two way learning opportunities. They were not sufficiently explicit about their learning needs. Specialists preferred to concentrate on new developments in their subject and would benefit from learning different ways of teaching. The participants were willing to learn from each other. Three models of educational interaction were identified: traditional didactic lectures given by specialists to general practitioners, interactive clinically based teaching, and informal interaction based on referrals.

Conclusions: The two main branches of the medical profession have to address several significant problems before the full potential of teaching and learning together can be realised.

Institute of General Practice,
Postgraduate Medical School,
University of Exeter, Exeter EX2 5DW
Martin N Marshall, lecturer

Full text on BioMedNet


Home | Current contents | Past issues | Classified ads | Career Focus | Feedback
Collections | About this site | About the BMJ | BMA | Medline